Imugene Market Cap

Imugene has a market cap or net worth of 75.56 million as of March 6, 2026. Its market cap has decreased by -74.02% in one year.

Market Cap

75.56M

Enterprise Value

66.40M

Revenue

3.94M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.24

Market Cap Chart

Since September 17, 2002, Imugene's market cap has increased from 7.38M to 75.56M, an increase of 923.97%. That is a compound annual growth rate of 10.41%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	75.56M	-34.72%
Dec 31, 2025	115.75M	-57.94%
Dec 31, 2024	275.18M	-65.11%
Dec 29, 2023	788.60M	-15.31%
Dec 30, 2022	931.15M	-59.62%
Dec 31, 2021	2.31B	386.45%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
LTR Pharma	81.80M
Radiopharm Theranostics	74.43M
Cynata Therapeutics	84.30M
Alterity Therapeutics	87.00M
Arovella Therapeutics	94.16M
Prescient Therapeutics	63.09M
Neurizon Therapeutics	57.16M
Amplia Therapeutics	56.44M

Market Cap Rankings